SPRAY-DRIED FORMULATION OF A PYRIDAZINONE TRPC5 INHIBITOR

Disclosed are spray-dried formulations of 4-chloro-5-(4-(4-fluoro-2-(trifluoromethyl)phenoxy)-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl)pyridazin-3(2H)-one, methods and compositions for making the same, and solid dosage forms comprising the same. The dosage forms described herein are useful in meth...

Full description

Saved in:
Bibliographic Details
Main Authors CORSON DONALD, STUMPFIG THOMAS E, SMITHEY DANIEL T, KWONG ELIZABETH CHU, SCHLESINGER ERICA B
Format Patent
LanguageChinese
English
Published 11.02.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are spray-dried formulations of 4-chloro-5-(4-(4-fluoro-2-(trifluoromethyl)phenoxy)-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl)pyridazin-3(2H)-one, methods and compositions for making the same, and solid dosage forms comprising the same. The dosage forms described herein are useful in methods of treating kidney diseases or neuropathies associated with diseases or conditions, and in methods of treating pain, anxiety, or depression. 本发明公开了4-氯-5-(4-(4-氟-2-(三氟甲基)苯氧基)-5,8-二氢吡啶并[3,4-d]嘧啶-7(6H)-基)哒嗪-3(2H)-酮的喷雾干燥制剂、用于制备其的方法和组合物、以及包含其的固体剂型。本文所述的剂型可用于治疗与疾病或病症相关联的肾脏疾病或肾病的方法以及治疗疼痛、焦虑症或抑郁症的方法中。
Bibliography:Application Number: CN202080042992